February 22, 2021

XRSI Roundtable: Part 2

Immersive technology presents a great deal of opportunity across all industries, none more so than in healthcare and mental health, but due to a lack of regulation, innovation also has the potential to result in dangerous or unethical practices.

Part two of the roundtable series was hosted by Dr James Somauroo, host of The HealthTech podcast, healthtech contributor for Forbes and founder of healthtech communications agency somX, along with our panel of experts:

Rachel Michelson – Medical XR advisor at XRSI. Rachel holds a degree in computer engineering from MIT and has experience in software development for public safety and cybersecurity evaluation of IoT and medical devices.

Walter Greenleaf – Neuro and behaviour scientist and medical technology developer at Stanford University and Colorado Mental Health Innovation Centre. With over three decades of research and development experience, Walter is considered a leading authority in digital medicine and medical XR technology. He also works as an advisor to start-ups, pharmaceutical and medical device companies.

Dr Charles Nduka – Consultant plastic and reconstructive surgeon specialising in facial reanimation following facial nerve palsy. He is also Co-founder and Chief Scientific Officer of emteq labs and recently joined XRSI as a member of the Medical Advisory Board.

Evidence for clinical effectiveness and immersive technologies
Evidence and data undoubtedly provide a cornerstone for building trust with clinicians and users. Immersive technologies are still in the very early stages of growing that critical body of evidence, although there is now primary research emerging that is beginning to build those foundations. Numerous academic research groups are also exploring how XR can be used to address a broad range of clinical applications such as autism, cognitive ageing, stroke rehabilitation and even addiction. In order to build genuine trust in XR, large-scale clinical trials for the most up-to-date technologies are needed, in the same way as a new medicine. However, research of this kind takes time and significant investment, and unlike medicines and molecular therapies, technology moves so quickly that research of today may be of little use tomorrow.

Put simply, research must be accelerated in large samples to validate clinical applications – given the experience of pharma and medtech in achieving this, there is great opportunity to collaborate and share learnings that can help to address these issues.

Making Global Impact
The biggest challenges in healthcare are well known – an ageing population, a mental health crisis, a global pandemic, lack of access to healthcare and growing demand against limited resources. These are all issues that existing systems around the world are not well equipped to fully address at scale, in a sustainable way. By contrast, technology provides the opportunity to reach more people, more efficiently in a more cost-effective way. As VR advances and becomes cheaper, mobile phone technology can be used to bridge the gap in sustainability, whilst also enabling a greater level of personalisation. Virtual avatars could even be used to create engaging patient content and wearables will also provide more information to adapt and target interventions and therapies according to individual need.

Making XR safer
Currently standards for how data is collected, aggregated and modelled are insufficient and there is not yet a significant understanding of the long-term impact of XR technology on the brain. As a worldwide not-for-profit organisation that promotes privacy, security, and ethics in immersive environments, XRSI is dedicating its efforts to developing and enforcing new standards that focus on key issues like privacy and child safety. To support this much needed progress, it is clear that responsibility for using XR in a safe and ethical way is the responsibility of the many, not just a few and therefore all stakeholders in the space must contribute in a meaningful way.

Get in touch with emteq labs:
www.emteqlabs.com | info@emteqlabs.com

Get in touch with the guests:
https://www.linkedin.com/in/waltergreenleaf/
https://www.linkedin.com/in/rmichelson/

To learn more about the organisations and initiatives mentioned in the podcast: https://xrsi.org/

Virtual human interaction lab at Stanford -https://vhil.stanford.edu/
National mental health innovation centre at the University of Colorado – https://www.cuanschutz.edu/centers/national-mental-health-innovation

You may also like

Revolutionising the User Experience with Immersive Technologies

On this week’s episode of Emotion Lab, Graeme Cox is joined by David Ripert from Poplar Studio. Poplar Studio is a creative platform that provides award-winning 3D and Augmented Reality (AR) experiences on-demand for marketing and commerce. Drawing upon David’s experiences at Netflix, Google and Youtube and his current role as UK President for the VR/AR Association, we discuss how immersive technologies are revolutionising user experiences across industries and use cases. David provides his unique insights on the future of immersive technologies. 

 

April 9, 2021

Read more

Improving digital experiences with audience psychology

On this week’s episode, Graeme is joined by Max Wiggins Insight and Innovation Lead at VERJ, a LAB Group agency. VERJ integrates science, innovation and design to uncover novel insights, solve client problems and develop creative solutions. With a background in cognitive neuroscience and psychology, Max uses his knowledge and expertise in human behaviours to solve commercial problems in digital environments and computational psychology to protect financially vulnerable adults.

March 22, 2021

Read more

Virtual interventions for youth psychosis with Professor Thompson

On this week’s episode of Emotion Lab, Dr. Charles Nduka is joined by Dr. Andrew Thompson.  Thompson is an expert in the field of youth psychiatry. His primary interest is in prevention or early intervention of first episode psychosis. We discuss the potential of virtual reality to overcome hurdles in social therapy, embody hallucinations and create a safe environment for exposure. 

March 8, 2021

Read more

About us

Objective measures of
emotional responses and behaviour

Location

  • Emteq Ltd.
    Sussex Innovation Centre,
    Brighton BN1 9SB,
    United Kingdom